Biocompatibility of electrochemical glucose sensors implanted in the subcutis of pigs

Diabetes Technology and Therapeutics

Volumn 8, Issue 4, 2006, Pages 463-475

  Kvist, Peter Helding ^a,b,c   Iburg, Tine ^b   Bielecki, Mia ^a   Gerstenberg, Michael ^a   Buch Rasmussen, Thomas ^a   Hasselager, Erik ^a   Jensen, Henrik Elvang ^b  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD3 EPSILON ANTIGEN; FIBRINOGEN; FIBRINOGEN FRAGMENT D; FIBRINOGEN FRAGMENT E; GLUCOSE; INTERLEUKIN 1; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HAPTOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIOFOULING; BIOSENSOR; DERMATITIS; DEVICE; ELECTROCHEMICAL GLUCOSE SENSOR; EVALUATION; FEMALE; FOREIGN BODY REACTION; GLUCOSE BLOOD LEVEL; GRANULOCYTE; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMPLANTATION; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL DETECTION; SWINE; T LYMPHOCYTE; TIME; ANIMAL; BLOOD GLUCOSE MONITORING; ELECTRODE; MATERIALS TESTING; METABOLISM; METHODOLOGY; PATHOLOGY; SUBCUTANEOUS TISSUE;

ANIMALS; BLOOD GLUCOSE SELF-MONITORING; ELECTRODES, IMPLANTED; FEMALE; GLUCOSE; HAPTOGLOBINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MATERIALS TESTING; SUBCUTANEOUS TISSUE; SWINE;

EID: 33750623254     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.463     Document Type: Article

References (39)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986 .
2. Bode BW, Sabbah H, McCulloch K: Continuous glucose monitoring facilitates lowering HbA1c levels in poorly controlled diabetes: results of a randomized, controlled study [abstract]. Diabetes 2001;50:A431.
3. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;46:183-190.
4. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-1862.
5. Boullu-Sanchis S, Jeandidier N, Siboenaler A, Boeckler P, Finget M, Meyer L: Glycemic stability evaluation in type 1 diabetic patients using continuous glucose monitoring sensor (CGMS) data: evaluation of classical and validated parameters [abstract]. Diabetologia 2002;45(Suppl 2):A280.
6. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW: Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet Med 2003;20:238-241.
7. Wiedmeyer CE, Johnson PJ, Cohn LA, Meadows RL: Evaluation of a continuous glucose monitoring system for use in dogs, cats, and horses. J Am Vet Med Assoc 2003;223:987-992.
8. Ishizaka T, Sato T, Kato K, Ohba M, Kimotsuki T, Yasuda M: Subcutaneous continuous glucose monitoring and dose adjustment decreases glycosylated hemoglobin in spontaneously diabetic cynomolgus monkeys. Contemp Top Lab Anim Sci 2003;42:36-40.
9. Davison LJ, Slater LA, Herrtage ME, Church DB, Judge S, Ristic JM, Catchpole B: Evaluation of a continuous glucose monitoring system in diabetic dogs. J Small Anim Pract 2003;44:435-442.
10. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ: Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999;277:E561-E571.
11. Cote GL, Lee RM, Pishko MV: Emerging biomedical sensing technologies and their applications. IEEE Sens J 2003;3:251-266.
12. Gerritsen M, Jansen JA, Kros A, Nolte RJ, Lutterman JA: Performance of subcutaneously implanted glucose sensors: a review. J Invest Surg 1998;11:163-174.
13. Rebrin K, Fischer U, Hahn-von D, von Woetke T, Abel P, Brunstein E: Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? J Biomed Eng 1992;14:33-40.
14. Pickup JC: In vivo glucose monitoring: sense and sensorbility. Diabetes Care 1993;16:535-539.
15. Mang A, Pill J, Gretz N, Kranzlin B, Buck H, Schoemaker M, Petrich W: Biocompatibility of an electrochemical sensor for continuous glucose monitoring in subcutaneous tissue. Diabetes Technol Ther 2005;7:163-173.
16. Wientjes KJ, Vonk P, Vonk-van Klei Y, Schoonen AJ, Kossen NW: Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers. Diabetes Care 1998;21:1481-1488.
17. Rahaghi FN, Goor JB, Makale MT, Gough DA: Factors that confound the tissue glucose sensor response [abstract]. Diabetes Technol Thep 2005;7:406.
18. Wisniewski N, Rajamand N, Adamsson U, Lins PE, Reichert WM, Klitzman B, Ungerstedt U: Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol Endocrinol Metab 2002;282:E1316-E1323.
19. Wollina U, Berger U, Mahrle G: Immunohistochemistry of porcine skin. Acta Histochem 1991;90:87-91.
20. Sullivan TP, Eaglstein WH, Davis SC, Mertz P: The pig as a model for human wound healing. Wound Repair Regen 2001;9:66-76.
21. Meyer W, Schwarz R, Neurand K: The skin of domestic mammals as a model for human skin with special reference to the domestic pig. Curr Probl Dermatol 1978;7:39-52.
22. Wilson GS, Hu YB: Enzyme based biosensors for in vivo measurements. Chem Rev 2000;100:2693-2704.
23. Wilkins E, Atanasov P: Glucose monitoring: state of the art and future possibilities. Med Eng Phys 1996;18:273-288.
24. Bancroft JD, Stevens A: Theory and Practice of Histological Techniques. New York: Churchill Livingstone, 1996.
25. Luna LG: Manual of Histopathologic Staining Methods of the Armed Forces Institute of Pathology. American Registry of Pathology. New York: McGraw-Hill, 1960.
26. Lauritzen B, Lykkesfeldt J, Skaanild MT, Angen O, Nielsen JP, Friis C: Putative biomarkers for evaluating antibiotic treatment: an experimental model of porcine Actinobacillus pleuropneumoniae infection. Res Vet Sci 2003;74:261-270.
27. Enemark HL, Bille-Hansen V, Lind P, Heegaard PM, Vigre H, Ahrens P, Thamsborg SM: Pathogenicity of Cryptosporidium parvum-evaluation of an animal infection model. Vet Parasitol 2003;113:35-57.
28. Tanimoto T, Ohtsuki Y: Evaluation of antibodies reactive with porcine lymphocytes and lymphoma cells in formalin-fixed, paraffin-embedded, antigen-retrieved tissue sections. Am J Vet Res 1996;57:853-859.
29. Brown PJ, Bourne FJ: Distributions of immunoglobulin-containing cells in alimentary tract, spleen, and mesenteric lymph node of the pig demonstrated by peroxidase-conjugated antiserums to porcine immunoglobulins G, A, and M. Am J Vet Res 1976;37:9.
30. Horák V, Hruban V, Dvorak P: The tissue distribution of Ia- and IgM-positive cells in adult and newborn miniature pigs. Zentralbl Veterinarmed [C] 1989;18:157-164.
31. Slauson D, Cooper B: Mechanisms of Disease. A Textbook of Comparative General Pathology. St. Louis, MO: Mosby, 2002.
32. Sitrin RG, Pan PM, Srikanth S, Todd RF III: Fibrinogen activates NF-κB transcription factors in mononuclear phagocytes. J Immunol 1998;161:1462-1470.
33. Rubel C, Fernandez GC, Dran G, Bompadre MB, Isturiz MA, Palermo MS: Fibrinogen promotes neutrophil activation and delays apoptosis. J Immunol 2001;166:2002-2010.
34. Harley SL, Powell JT: Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells. Biochem J 1999;341:739-744.
35. Petersen HH, Nielsen JP, Heegaard PM: Application I of acute phase protein measurements in veterinary I clinical chemistry. Vet Res 2004;35:163-187.
36. Steel DM, Whitehead AS: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-88.
37. Petersen HH, Ersboll AK, Jensen CS, Nielsen JP: Serum-haptoglobin concentration in Danish slaughter pigs of different health status. Prev Vet Med 2002;54:325-335.
38. Eckersall PD, Saini PK, McComb C: The acute phase response of acid soluble glycoprotein, α1-acid glycoprotein, ceruloplasmin, haptoglobin and C-reactive protein, in the pig. Vet Immunol Immunopathol 1996;51:377-385.
39. Murata H, Shimada N, Yoshioka M: Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J 2004;168:28-40.